By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
General Principles of Software Validation
- By: Staff Editor
- Date: December 04, 2016
- Source: http://www.fda.gov/
Compliance Webinars | Virtual Seminars for Professionals
General Principles of Software Validation
Software validation is a vital tool used to assure the quality of software and software automated operations for medical devices. Software validation can increase the reliability and accuracy of the device, subsequently leading to fewer recalls and corrective actions, less risk to patients, decreased failure rates, and reduced liability to device manufacturers.
The FDA guidance details the general validation principles that are appropriate to the validation of device software or the validation of software used to design, develop, or manufacture medical devices.
Applicability
This rule applies to:
- Software used as a part, or accessory of a medical device
- Software that is itself a medical device e.g., blood establishment software
- Software used in the manufacture of a device e.g., programmable logic controllers in manufacturing equipment
- Software used in application of the device manufacturer's quality system e.g., software that records and maintains the device history record.
Software Validation Requirements
Software validation is a requirement of the Quality System Regulation (QSR), which became effective on June 1, 1997. The FDA dictates that software used for the design, manufacture, packaging, labeling, storage, installation, and servicing of all devices should be validated. Since then, regardless of the device class, unless specifically exempted all device software products are subjected to applicable design control provisions (21 CFR §820.30.).
Additionally, validation requirements also applies to computes system used to generate, change and maintain electronic records and electronic signatures.
Related Training:
The 6 Most Common Problems in FDA Software Validation & Verification
Software Validation: Avoiding FDA Warning Letters and Consent Decree
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
Add to CartSan Francisco, CA | Aug 6-7, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 18-19, 2020
-
Add to CartLos Angeles, CA | Aug 20-21, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 25-26, 2020
-
Add to CartVirtual Seminar | Jun 10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | Jul 6-7, 2020
-
Add to CartSan Francisco, CA | Oct 22-23, 2020
-
Add to CartVirtual Seminar | Jul 9-10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | June 3-4, 2020
-
Add to CartMiami, FL | Jul 29-31, 2020
-
Add to CartVirtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart







